Authors

• Theodore S. Steiner (ORCID: https://orcid.org/0000-0002-3136-6668)
• W Knapple (ORCID: https://orcid.org/0009-0007-4081-3304)
• Brian Baggott
• Lindy Bancke
• Beth Guthmueller
• Nicholas W. Van Hise
• Erik R. Dubberke (ORCID: https://orcid.org/0000-0003-3779-2796)
• Paul Feuerstadt (ORCID: https://orcid.org/0000-0002-7643-9576)
• Teena Chopra (ORCID: https://orcid.org/0000-0003-1185-4549)
• Sahil Khanna (ORCID: https://orcid.org/0000-0002-7619-8338)
• Daniel Van Handel
• Michael Gamborg

Institutions

• Cleveland Clinic (US)
• Mayo Clinic (US)
• University of British Columbia (CA)
• Wayne State University (US)
• Washington University in St. Louis (US)
• Ferring Pharmaceuticals (Switzerland) (CH)
• WinnMed (US)
• Yale University (US)
• Vancouver Infectious Diseases Centre (CA)
• Infectious Disease Consultants (US)
• Ferring Pharmaceuticals (United States) (US)
• MNGI Digestive Health (US)
• Zimmer Biomet (Switzerland) (CH)

Publication Details

Journal

Clinical Infectious Diseases

Published

2024-08-23

DOI

https://doi.org/10.1093/cid/ciae437

Citations

25

Primary Topic

Clostridium difficile and Clostridium perfringens research

Type

article

Field-Weighted Citation Impact

9.73

Funders

• Ferring Pharmaceuticals